Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Clinical trial NCT00002753 · COMPLETED

Trial details

NCT number: NCT00002753
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1991-11-01
Primary completion: 2001-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.